Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea.

GeneOne Life Science, Inc. engages in the research, development, and manufacture of deoxyribonucleic acid (DNA) vaccines for the prevention and treatment of diseases. Its products include VGX-3400, VGX-3500, and fluorine. Its service includes process cost analysis, sterility testing, research batch production, strain selection, cell bank characterization, and others. It also conducts pre-clinical trials for the treatment of hepatitis C. In addition, it is involved in contract manufacturing activities for pre-clinical and clinical trials for companies and institutions. The company was founded on January 27, 1976 and is headquartered in Seoul, South Korea.

Zhejiang Pukang Biotechnology Co., Ltd., established on 2000-03-30, Business scope includes pharmaceutical production,operate(The operating permit),medicine,Research and development of biological products,engaged in import and export business,road freight transport(The operating permit),Medical Technology Development,technical consulting,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nobelpharma was founded in 2003, and in 2008 we obtained our first marketing approval for an ethical drug, NOBELZIN®. We now have marketing approvals for and sell 18 new drugs and one new medical device. In the pharmaceuticals industry, there are no companies of similar scale and age launching as many new drugs as we have. It is the pursuit of our unique product planning and research and development that has led to this achievement. We engage in the projects of "drugs and medical devices for unmet medical needs" which are critical but neglected. We chose not to carry out the time-consuming and costly basic researches. Instead, we conduct license negotiations and research activities focusing on patient needs and select the best possible candidates (new drug candidates) from outside our company. This is because we want to deliver the drugs and medical devices for unmet medical needs to the medical front as quickly as possible, for the benefit of the patients. Unique management strategy for

Ustar Biotechnologies (Hangzhou) Ltd. develops and manufactures molecular diagnostic products. Its products include DNA extraction, TB testings, STD testings and DNA detection. The company was founded by Qimin You and Michael Hu in 2005 and is headquartered in Hangzhou, China.

Jiangsu Provincial People's Hospital, a subsidiary of Nanjing Medical University, is a company headquartered in Guangzhou, China. The firm operates hospitals.

Zhengzhou Yimeno Biotechnology Co., Ltd., established on 2007-11-06, Business scope includes biological materials and consumables,Chemical Materials and Consumables(Excluding flammable and explosive hazardous chemicals),medical instruments,Office Supplies,Technical research and development of experimental equipment and consumables,technical consulting,Technical Services,Production,Sales;Warehousing Services(Excluding flammable and explosive hazardous chemicals);road general cargo transportation,Dedicated road freight transport(Refrigeration and preservation equipment);Biotechnology,Technology research and development of computer software and hardware,technical consulting,Technical Services;Sales of computer hardware and software;Import and export of goods or technology.

Yuandaolong (Suzhou) Medical Technology Co., Ltd., established on 2013-04-18, Business scope includes research and development of biological and nanotechnology,Technology Transformation and Technology Transfer;Exhibition business service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Green + Joint Stock Corp. engages in the manufacture and distribution of pharmaceutical and herbal products. The company was founded in 2016 and is headquartered in Ben Tre, Vietnam.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Wuxi Xinlianxin Biomedical Technology Co., Ltd., established on 2010-10-12, Business scope includes research and development of vaccines,medicine,drug,Research and development of biotechnology drugs and related technologies,technical consulting,Technical Services,technology transfer,Technical testing;Development of diagnostic reagents;R&D and sales of biochemical preparations(Does not contain dangerous goods);Self-operated and agent import and export of various commodities and technologies(Except for commodities and technologies that the state restricts the company to operate or prohibits the import and export of);own house,General mechanical equipment and its accessories,Professional setting,Car rental(Excluding finance lease).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

SL BIGEN is a research and development business that aims to save patients' lives through bio-genetic engineering. SL BIGEN is working on two projects: I a first-in-class mesenchymal stem cell line engineered to express disease-specific therapeutic genes, and (ii) a multi-engineered natural killer cell line expressing fourth generation chimeric antigen receptors. Cancer and neurological illnesses are among the therapeutic areas covered by the company.

Develops and sells in-vitro diagnostic drugs, reagents and equipment

Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics products and equipment. It operates through following business divisions: Clinical Diagnostics and Testing of Food and Environment. The Clinical Diagnostics division handles the manufacture of clinical diagnostic products and services. The Testing of Food and Environment division deals with the sale of reagents for microbiological tests on food for poisoning bacteria, and environment for contamination of work environments. Its products include fecal immunochemical testing equipment, molecular test loop-mediated isothermal amplification (LAMP), immunological and serological reagents, and rapid diagnostic tests such as IMMUNOCATCH Norovirus, IMMUNOCATCH Legionella, and IMMUNOCATCH Streptococcus pneumoniae. The company was founded on February 20, 1939 and is headquartered in Tokyo, Japan.

CanSino Biologics, Inc. engages in the research and development, manufacturing, and sale of vaccines. It offers shingles, meningitis, polio, adenovirus, and tuberculosis vaccines. The company was founded by Xuan Liu, Xue Feng Yu, Tao Zhu, Dong Xu Qiu and Hui Hua Mao on January 13, 2009 and is headquartered in Tianjin, China.

Median Diagnostics Inc. engages in the manufacture and supply of in vitro diagnostic products for animal diseases and raw materials for human disease diagnosis. It operates through the following business divisions: Enzyme immunoassay method, Gene amplification diagnosis, Rapid diagnosis and Raw materials. The Enzyme immunoassay method business division offers enzyme-linked immunosorbent assay for bovine, swine and poultry. The Gene amplification diagnosis business division provides polymerase chain reaction kits. The Rapid diagnosis business division offers rapid kits such as companion animals rapid kit, livestock and poultry animals rapid kit. The Raw materials business division provides biologicals such anti-hemoglobin, malaria plasmodium and anti-malaria. The company was founded on October 18, 1999 and is headquartered in Chuncheon-si, South Korea.

SL VaxiGen, Inc. operates as research and development company which engages in developing vaccine therapeutics based on complementary platforms for saving lives. The company was founded on March 3, 2017 and is headquartered in Seongnam, South Korea.